Yeshwant Krishna 4
4 · Verve Therapeutics, Inc. · Filed Jun 20, 2023
Insider Transaction Report
Form 4
Yeshwant Krishna
Director10% Owner
Transactions
- Award
Stock Option (right to buy)
2023-06-15+26,642→ 26,642 totalExercise: $19.84Exp: 2033-06-14→ Common Stock (26,642 underlying)
Footnotes (1)
- [F1]This stock option was issued pursuant to the 2021 Stock Incentive Plan of Verve Therapeutics, Inc. in accordance with its director compensation program. The vesting commencement date (the "Vesting Commencement Date") of the options is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or immediately prior to the first annual meeting of stockholders occurring after the grant date, in each case subject to the Reporting Person's continued service as a director.